Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell Line Designation Change: Multidrug-Resistant Cell Line in the NCI Anticancer Screen

3 Jun 1998

Abstract excerpt

Since 1990, the Developmental Therapeutics Program (DTP) of the National Cancer Institute (NCI) has screened over 60 000 compounds and a larger number of natural product extracts for their capacity to inhibit the growth of 60 different human tumor cell lines (1). These cell lines have been maintained in cryopreservation and in culture, and they have been subjected to strict quality controls, including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Research and Treatments
Share to Cancer therapeutics and mechanisms
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9625176
DOI: 10.1093/jnci/90.11.862

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Cell Line Designation Change: Multidrug-Resistant Cell Line in the NCI Anticancer ScreenPMID 9625176Read ↗

Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.Semantic proximity Read ↗

Development of Drug-resistant Cell Lines for Experimental ProceduresSemantic proximity Read ↗

A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells.Semantic proximity Read ↗

Analysis of TP53 mutation status in human cancer cell lines: a reassessment.Semantic proximity Read ↗

Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.Semantic proximity Read ↗

Drug Resistance in Hematological MalignanciesSemantic proximity Read ↗

Establishment of in-vitro models of chemotherapy resistance.Semantic proximity Read ↗

Genetic and transcriptional evolution alters cancer cell line drug response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.